The research team has transformed cinnamaldehyde into a prodrug form through chemical modification, which can effectively improve the solubility and stability of the drug, enhancing its therapeutic efficacy. Credit: The University of Hong Kong A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilizing cinnamaldehyde, a common food additive, as an anti-inflammatory agent. The prodrug forms nanoparticles that deliver the therapeutic agents precisely to the inflamed sites, offering a solution for the treatment of Read More